Pharmaceutical Preparations · DE · CIK 1574094
RenovoRx, Inc. develops drug/device combination products and a proprietary drug delivery device
Comparable business profile · signals at a glance
In the 90 days to Mar 20, 2026: 4 insiders bought $19K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 20, 2026 | Marton LaurenceDirector | Buy | 9,720 | — | — |
| Mar 20, 2026 | Bagai ShaunChief Executive Officer | Buy | 24,300 | — | — |
| Mar 20, 2026 | Voll MarkChief Financial Officer | Buy | 97,200 | — | — |
| Jan 21, 2026 | Agah RamtinChief Medical Officer | Buy | 10,000 | $1.00 | $10K |
| Dec 31, 2025 | Agah RamtinChief Medical Officer | Buy | 9,795 | $0.86 | $8K |
| Dec 30, 2025 | Agah RamtinChief Medical Officer | Buy | 205 | $0.83 | $170 |
| Dec 18, 2025 | Bagai ShaunChief Executive Officer | Buy | 5,000 | $0.90 | $5K |
| Dec 17, 2025 | Bagai ShaunChief Executive Officer | Buy | 5,000 | $0.85 | $4K |
| Dec 16, 2025 | Agah RamtinChief Medical Officer | Buy | 12,000 | $0.85 | $10K |
| Dec 5, 2025 | Agah RamtinChief Medical Officer | Buy | 10,000 | $0.96 | $10K |
| Nov 24, 2025 | Agah RamtinChief Medical Officer | Buy | 12,000 | $0.80 | $10K |
| Nov 21, 2025 | Agah RamtinChief Medical Officer | Buy | 10,000 | $0.80 | $8K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.